Home » Newsletters » BioWorld Science

BioWorld Science

April 5, 2022

View Archived Issues

HCAR2 targeting modulates the progression of AD in mice

IRF3 orchestrates obesity-induced inflammation and dysglycemia

Inhaled bispecific single-domain antibody neutralizes multiple SARS-CoV-2 variants

Allosteric regulators targeting GCase decrease toxic substrate accumulation in models of GD

Novel carbazole derivatives attenuate mitochondrial function in models of lung adenocarcinoma

Chengdu Origiant Pharmaceutical patents RIPK1 inhibitors

Guangzhou Maxinovel Pharmaceuticals discloses PD-1/PD-L1 interaction inhibitors

Betta Pharmaceuticals presents new CD73 inhibitors

J2H Biotech identifies new PROTACs for NSCLC

Compass Pathfinder synthesizes new safrylamine derivatives

LUM-015 shows potential for imaging of inflammatory protease activity in atherosclerosis

Tollovir and Tollovid show 3CL protease inhibition in vitro against Omicron SARS-CoV-2 variants

Aligos selects broad-spectrum coronavirus protease inhibitor ALG-097558 for advancement

CARB-X option funding supports Clarametyx's development of anti-biofilm therapy CMTX-101

Plasma desmosine is a prognostic factor in acute myocardial infarction

TEM1 is a marker of heart failure severity

Gut reaction to rapamycin extends female fly lifespan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...